Navigation Links
BioMarin to Present at the Morgan Stanley Healthcare Conference
Date:4/24/2008

NOVATO, Calif., April 24 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that Emil Kakkis, M.D., Ph.D., Chief Medical Officer of BioMarin, will present a company update at the Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, Florida on Thursday, May 1, 2008 at 5:00 p.m. ET.

Interested parties may access a live audio webcast of the presentation via the investor section of the BioMarin website, http://www.BMRN.com. A replay of the presentation will be archived on the site for at least one week following the presentation.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(TM) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include 6R-BH4 for cardiovascular indications, which is currently in Phase 2 clinical development for the treatment of peripheral arterial disease and sickle cell disease, and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of PKU. For additional information, please visit http://www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

BioMarin(R) and Naglazyme(R) are registered trademarks of BioMarin Pharmaceutica
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
9. BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET)
10. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
11. Avicena Group to Present at Noble Financial Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... NDA with FDA in Early to Mid-2009 , , WOOD... Strativa Pharmaceuticals, the proprietary product...NYSE: PRX ) today announced that its development...letion of all pivotal bioequivalence studies for a...tron thin film product is being developed for the ...
(Date:12/2/2008)...., Dec. 2 GeneGo, Inc., the leadin...hat Burnham has become a certified GeneGo Center o...ution-wide access to GeneGo,s MetaCore data analys...ham institute is a world-class biomedical research...ies throughout many departments, including researc...
(Date:12/2/2008)..., Israel, December 2 InSightec Ltd... Magnetic Resonance-guided Focused,Ultrasound (MR...l to be an,effective noninvasive pain-relieving t... (bone metastases). The results of a 31 patient st...als of Surgical Oncology, while data from an,elev...
(Date:12/2/2008)...OLIS, France, December 2 ...unced it has signed an agreement with,DSM for the...drug substance,(or API, active pharmaceutical ing...nal product and the first compound in the,Cycloox...lass of,anti-inflammatory agents, which recently ...
Breaking Biology Technology:Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
..., , , , , , Multiporator ... , , , , Trans... 915.508 12/2001 , , , , ... , Microorganism , Bruce...ll type , Bacteria, gram negative, ...
... , , , , , , , Ni...e Wagner , Nicole Passaretti, Vincent Pre...stbury, NY , Susanne WagnerEppendorfNethele... , , , Plasmids are naturally occur... cell, which can replicate independently but (usua...
..., , , , , , Multiporator ... , , , , Trans... 915.539 04/2002 , , , , ... , Microorganism , Actin..., Cell type , Bacteria, gram...
..., , , , , , Other importan..., , , , , , , ...lse length , , Number of ,... , of the electroporation buffer , ... Influence , of temperature ,...
Other Biology Technology:Brucella abortus 2Efficient Recovery of Ultrapure Plasmid DNA 2Efficient Recovery of Ultrapure Plasmid DNA 3Efficient Recovery of Ultrapure Plasmid DNA 4Actinobacillus pleuropneumoniae 2
(Date:12/2/2008)...e in German . ,, Where would we be witho...r, for that matter, to forget irrelevant details? ...unication units, called synapses, we are good at b...se was believed to play an active role in this reo...rlie our ability to learn but also to forget. An i...
(Date:12/1/2008)...nimals find their way back to their birthplace to ...s of open ocean has mystified scientists for more ...rsity of North Carolina at Chapel Hill think they ...e beginning of their lives, salmon and sea turtles...d "imprint" on it, according to a new theory in th...
(Date:12/1/2008)...ts around the world may benefit from a powerful ne...elp them to home in on the parts of proteins most ..., associate professor of pathology and of genetics...cently launched the novel bioinformatics tool, whi...he role different proteins play in a wide array of...
(Date:12/1/2008)... Sciences will hold a colloquium to examine what l... niches of organisms. Leading researchers and stud...erns of distribution and even evolution from the p...s, and biodiversity informatics dealing with micro...oquium series, the event will take place at the Ar...
Breaking Biology News(10 mins):It takes 2 to tango 2It takes 2 to tango 3No place like home: New theory for how salmon, sea turtles find their birthplace 2No place like home: New theory for how salmon, sea turtles find their birthplace 3Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Many Ignore Symptoms of Bladder Trouble 29909 1Many Ignore Symptoms of Bladder Trouble 29909 2Putting a new spin on current research 9219 1Genetics of aging and cancer resistance 29903 1TRIDELITY Display Solutions Partners With Two Of The World 26apos 3Bs Leading Imaging Software Companies 9216 1TRIDELITY Display Solutions Partners With Two Of The World 26apos 3Bs Leading Imaging Software Companies 9216 2TRIDELITY Display Solutions Partners With Two Of The World 26apos 3Bs Leading Imaging Software Companies 9216 3
...mary strategies for regulating its genome is a kin... molecules called microRNAs, or miRNAs. First obse...to inactivate messenger RNA, itself responsible fo... been eager to know more about miRNAs, clearly imp... gone unnoticed for so long. How are they produced...
...lts from a study in Botswana, Harvard School of Pu...h HIV-1 subtype C in resource-poor settings, who r...omparable results to those in the developed world.... infrastructure help ensure this success, accordin...Journal of Acquired Immune Deficiency Syndromes (J...
...thogens, the Chlamydiae know us very, very well. T...ls half a billion years ago by reprogramming cellu...dial infections are responsible for a range of ail...ical pneumonias to chronic severe disorders such a... The Centers for Disease Control says that Chlamyd...
... reported this week in Current Biology, tsunami da...e 2004 Sumatra-Andaman earthquake was occasionally...ly when compared to damage from chronic human misu...tsunami of December 26, 2004, a team of ecologists...tion Society-Indonesia Program, and Syiah Kuala Un...
Other Biology News:Twin molecular scissors link creation of microRNAs with gene-silencing 2Largest computational biology simulation mimics life’s most essential nanomachine 2Chlamydia parasite lives off our fat 2
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody
...hthoyl-VF-CHO White lyophilized solid. PROTECT F...ble, reversible inhibitor of γ-secretase. Eq...ED 50 = 2.6 μM) and Aβ x-42 (ED 50 = 2....he Amyloid Precursor Protein Swedish mutants. Pur...
Mlu I from New England Biolabs
Corticoliberin
Biology Products: